A detailed history of Rtw Investments, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Rtw Investments, LP holds 2,721,158 shares of CYTK stock, worth $140 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares
2,721,158
Previous 2,525,080 7.77%
Holding current value
$140 Million
Previous $177 Million 16.72%
% of portfolio
2.46%
Previous 2.84%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $9.38 Million - $14.7 Million
196,078 Added 7.77%
2,721,158 $147 Million
Q4 2023

Feb 14, 2024

SELL
$26.88 - $83.49 $1.32 Million - $4.1 Million
-49,118 Reduced 1.91%
2,525,080 $211 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $501,636 - $709,632
13,016 Added 0.51%
2,574,198 $125 Million
Q4 2021

Feb 14, 2022

BUY
$34.35 - $46.38 $19.3 Million - $26 Million
561,182 Added 28.06%
2,561,182 $117 Million
Q3 2020

Nov 16, 2020

BUY
$20.58 - $28.96 $41.2 Million - $57.9 Million
2,000,000 New
2,000,000 $40.7 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.85B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.